Phase 1 clinical trials in oncology

Comment

Ikuo Sekine et al. N Engl J Med. 2005.

. 2005 Jun 9;352(23):2451-3; author reply 2451-3.

No abstract available

Comment on

Risks and benefits of phase 1 oncology trials, 1991 through 2002.
Horstmann E, McCabe MS, Grochow L, Yamamoto S, Rubinstein L, Budd T, Shoemaker D, Emanuel EJ, Grady C. Horstmann E, et al. N Engl J Med. 2005 Mar 3;352(9):895-904. doi: 10.1056/NEJMsa042220. N Engl J Med. 2005. PMID: 15745980
Risks and benefits of phase 1 oncology trials, revisited.
Kurzrock R, Benjamin RS. Kurzrock R, et al. N Engl J Med. 2005 Mar 3;352(9):930-2. doi: 10.1056/NEJMe058007. N Engl J Med. 2005. PMID: 15745986 No abstract available.